Recent Price Movement and Market Context
On 24 Nov 2025, Kopran's stock price touched Rs.126.6, the lowest level recorded in the past year. This decline comes after two consecutive days of losses, during which the stock has returned -5.52%. The day’s performance showed a drop of 1.71%, underperforming the Pharmaceuticals & Biotechnology sector by 1.68%. Kopran is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling sustained downward pressure.
In contrast, the broader market has shown resilience. The Sensex opened 88.12 points higher and was trading at 85,455.79, reflecting a 0.26% gain. The index is approaching its 52-week high of 85,801.70, just 0.4% away, and has recorded a 2.69% rise over the past three weeks. Mega-cap stocks are leading this positive momentum, with the Sensex trading above its 50-day moving average, which itself is positioned above the 200-day moving average, indicating a bullish trend in the broader market.
Long-Term and Recent Performance Metrics
Kopran’s one-year performance shows a return of -42.35%, a stark contrast to the Sensex’s 8.01% gain over the same period. The stock’s 52-week high was Rs.236.1, highlighting the extent of the decline. Over the last three years, as well as the past one year and three months, Kopran has underperformed the BSE500 index, reflecting challenges in maintaining competitive performance within its sector.
Fresh entry alert! This Small Cap from Electronics & Appliances sector is already turning heads in our Top 1% club. Get ahead of the market now!
- - New Top 1% entry
- - Market attention building
- - Early positioning opportunity
Financial Results and Profitability Trends
Kopran’s financial results have reflected a challenging environment. The company reported a fall in net sales by 22.2% in the September 2025 quarter, continuing a sequence of negative results over the last five quarters. The net profit after tax (PAT) for the quarter stood at a loss of Rs.9.92 crores, representing a decline of 234.4% compared to the previous period.
Return on Capital Employed (ROCE) for the half-year was recorded at 5.38%, one of the lowest levels in recent years. The operating profit to interest ratio for the quarter was -2.53 times, indicating that operating profits were insufficient to cover interest expenses. These figures point to subdued profitability and operational strain within the company’s financial structure.
Valuation and Debt Profile
Despite the subdued earnings, Kopran maintains a relatively low average debt-to-equity ratio of 0.23 times, suggesting limited leverage compared to many peers. The company’s ROCE of 4.7 and an enterprise value to capital employed ratio of 1.2 indicate that the stock is trading at a discount relative to historical valuations of its sector counterparts. However, this valuation discount accompanies a significant contraction in profits, which have fallen by 66.7% over the past year.
Shareholding and Market Interest
Domestic mutual funds hold a minimal stake of 0.01% in Kopran, a relatively small position given their capacity for detailed company research. This limited exposure may reflect a cautious stance towards the company’s current valuation and business performance.
Kopran or something better? Our SwitchER feature analyzes this micro-cap Pharmaceuticals & Biotechnology stock and recommends superior alternatives based on fundamentals, momentum, and value!
- - SwitchER analysis complete
- - Superior alternatives found
- - Multi-parameter evaluation
Sector and Market Comparison
Within the Pharmaceuticals & Biotechnology sector, Kopran’s recent performance contrasts with the broader market’s upward trajectory. While the Sensex and sector indices have shown resilience and gains, Kopran’s stock price and financial metrics have reflected ongoing pressures. The stock’s position below all major moving averages further emphasises the divergence from sector trends.
The company’s long-term growth rate for operating profit has been negative, at an annual rate of -11.79% over the last five years. This sustained contraction in profitability has contributed to the stock’s downward trajectory and its current valuation levels.
Summary of Key Metrics
To summarise, Kopran’s stock has reached Rs.126.6, its lowest point in 52 weeks, following a series of quarterly results showing declining sales and profits. The stock’s one-year return of -42.35% contrasts with the Sensex’s positive 8.01% return, underscoring the company’s relative underperformance. Financial indicators such as ROCE, operating profit to interest ratio, and net sales trends highlight ongoing challenges in profitability and growth.
While the company’s low debt levels and valuation discount relative to peers are notable, these factors coexist with a significant contraction in earnings and subdued market interest from institutional investors.
Limited Time Only! Subscribe for Rs. 12,999 and get 1 Year of MojoOne + an Additional Year Completely FREE. Don't miss out on this exclusive offer. Claim Your Free Year →
